Literature DB >> 21095305

Resection of solitary pulmonary lesion is beneficial to patients with a history of malignancy.

Miki Sakamoto1, Tomohiro Murakawa, Kentaro Kitano, Tomonori Murayama, Takehiro Tsuchiya, Jun Nakajima.   

Abstract

BACKGROUND: Solitary pulmonary lesion poses a diagnostic challenge, especially in patients with a history of malignancy. The purpose of this study was to evaluate the characteristics of solitary pulmonary lesions and the outcome of surgical resection.
METHODS: We retrospectively analyzed 243 patients with a history of cancer who underwent surgery for new-found solitary pulmonary lesion between January 1998 and December 2007.
RESULTS: The diagnosis was primary lung cancer in 92 patients, metastasis in 133, and benign lesions in 18. The 5-year survival rate was 67.9% in all patients, 74.6% in those with primary lung cancer, 62.8% in those with metastasis, and 79.9% in those with benign lesions (p = 0.56). In metastasis patients, history of extrapulmonary recurrence and larger diameter lesion were risk factors for recurrence by multivariate analysis. History of cancers other than colorectal and bone and soft tissue sarcoma and shorter disease-free interval were indicators of poor prognosis. Pathologic stage was the only indicator of prognosis for primary lung cancer, and none of the factors concerning antecedent cancer influenced prognosis.
CONCLUSIONS: Surgical resection of solitary pulmonary lesion is essential in patients with a history of cancer because substantial numbers of benign lesions are included. In the case of malignancy, metastasectomy had a life-prolonging effect for selected patients, and prognosis of primary lung cancer was no worse than for the general population if treated appropriately. It is important not to hesitate to take a surgical approach for a diagnosis and to treat with standard therapy for primary lung cancer.
Copyright © 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21095305     DOI: 10.1016/j.athoracsur.2010.07.054

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  A plea for thoracoscopic resection of solitary pulmonary nodule in cancer patients.

Authors:  Jocelyn Bellier; Jean Yannis Perentes; Etienne Abdelnour-Berchtold; Benjamin Lopez; Thorsten Krueger; Catherine Beigelman-Aubry; Hans-Beat Ris; Michel Gonzalez
Journal:  Surg Endosc       Date:  2017-04-13       Impact factor: 4.584

Review 2.  Imaging of solitary pulmonary nodule-a clinical review.

Authors:  Yee Ting Sim; Fat Wui Poon
Journal:  Quant Imaging Med Surg       Date:  2013-12

3.  Clinical Significance of Multiple Pulmonary Metastasectomy for Hepatocellular Carcinoma.

Authors:  Shinjiro Mizuguchi; Noritoshi Nishiyama; Nobuhiro Izumi; Takuma Tsukioka; Hiroaki Komatsu; Takashi Iwata; Shogo Tanaka; Shigekazu Takemura; Shoji Kubo
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

4.  Predictors of primary lung cancer in a solitary pulmonary lesion after a previous malignancy.

Authors:  Akie Nakadate; Masashi Nakadate; Yasunori Sato; Tassei Nakagawa; Katsuya Yoshida; Yoshio Suzuki; Yukihiro Yoshida
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-09-08

5.  Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis.

Authors:  Feng Xia; Lin Wu; Wan-Yee Lau; Guo Li; Hongbo Huan; Cheng Qian; Kuansheng Ma; Ping Bie
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

6.  Coil localization assisted wedge resection for pulmonary nodules in patients with malignant history.

Authors:  Qing-Song Xu; Tao Wang; Wei Cao; Pan-Hao Rong
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

7.  [Experience and Progress Processing Policy of Simultaneous Multiple Primary 
Lung Cancer].

Authors:  Liankui Han; Shugeng Gao; Fengwei Tan; Ziran Zhao; Peng Song
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.